Q1 2022 · 13F-HR
CHI Advisors LLCholdings as filed
Filed 2022-05-16 · accession 0001085146-22-002173
$235,165
Reported value
22
Positions
2022-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 74349U108 | — | PROMETHEUS BIOSCIENCES INC | $59,853 | 25.5% | 1,585,096 | Common | SOLE |
| 760273102 | RPTX | REPARE THERAPEUTICS INC | $36,755 | 15.6% | 2,581,097 | Common | SOLE |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $28,824 | 12.3% | 2,753,047 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $18,629 | 7.92% | 2,657,457 | Common | SOLE |
| H9060V101 | — | VECTIVBIO HLDG AG | $14,527 | 6.18% | 3,084,310 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $13,984 | 5.95% | 819,672 | Common | SOLE |
| 68217N105 | — | OMEGA THERAPEUTICS INC | $6,589 | 2.80% | 1,055,882 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $6,136 | 2.61% | 1,515,148 | Common | SOLE |
| 35655L107 | — | FREELINE THERAPEUTICS HLDGS | $5,446 | 2.32% | 4,862,319 | Common | SOLE |
| 49372L100 | — | KEZAR LIFE SCIENCES INC | $5,229 | 2.22% | 314,612 | Common | SOLE |
| 45175G108 | — | IKENA ONCOLOGY INC | $4,970 | 2.11% | 814,755 | Common | SOLE |
| 68236R103 | — | ONCORUS INC | $4,303 | 1.83% | 2,417,436 | Common | SOLE |
| 00973J101 | — | AKOUOS INC | $3,972 | 1.69% | 836,120 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $3,877 | 1.65% | 2,829,712 | Common | SOLE |
| 68570P101 | — | ORCHARD THERAPEUTICS PLC | $3,779 | 1.61% | 5,307,751 | Common | SOLE |
| 3621LQ109 | GTHXEUR | G1 THERAPEUTICS INC | $3,714 | 1.58% | 488,635 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $3,649 | 1.55% | 892,057 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $3,384 | 1.44% | 62,229 | Common | SOLE |
| 221015100 | CRVS | CORVUS PHARMACEUTICALS INC | $2,793 | 1.19% | 1,703,137 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $2,678 | 1.14% | 852,888 | Common | SOLE |
| 74019P108 | — | PRECISION BIOSCIENCES INC | $1,868 | 0.79% | 606,629 | Common | SOLE |
| 78464A870 | XBI | SPDR SER TR | $206 | 0.09% | 222,500 | PUT | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.